TrademarkDir
MEI PHARMA
LIVE

Serial Number

85575487

Owner

Marshall Edwards, Inc.

Attorney

Aaron D. Hendelman

First Use Date

Jul 2, 2012

Filing Date

Mar 21, 2012

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

MEI PHARMA Trademark

Serial Number: 85575487 • Registration: 4459693

MEI PHARMA is a trademark filed by Marshall Edwards, Inc. on March 21, 2012. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Marshall Edwards, Inc. (3 trademarks)

Suite 2i
New Canaan, CT 06840

Entity Type: 03

MEI Pharma Inc. (4 trademarks)

San Diego, CA 92130

Entity Type: 03

Trademark Details

Filing Date

March 21, 2012

Registration Date

December 31, 2013

First Use Anywhere

July 2, 2012

First Use in Commerce

May 29, 2013

Published for Opposition

July 17, 2012

Goods & Services

Pharmaceuticals for use in the treatment of oncological disorders, neurological disorders, and immune-related disorders

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Nov 5, 2024 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Nov 5, 2024 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Nov 5, 2024 89AG
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Oct 23, 2024 EROP
POST REGISTRATION ACTION MAILED - SEC. 8 & 9
Apr 23, 2024 PR89
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Apr 23, 2024 APRE
TEAS SECTION 8 & 9 RECEIVED
Dec 20, 2023 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Dec 31, 2022 REM2
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 4, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 4, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 4, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 4, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 4, 2021 COAR
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Feb 19, 2020 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Feb 19, 2020 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Feb 19, 2020 APRE
TEAS SECTION 8 & 15 RECEIVED
Dec 18, 2019 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Dec 31, 2018 REM1
REGISTERED-PRINCIPAL REGISTER
Dec 31, 2013 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Nov 23, 2013 SUNA
LAW OFFICE REGISTRATION REVIEW COMPLETED
Nov 22, 2013 REGV
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Nov 19, 2013 CNPR
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Oct 30, 2013 ASGN
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 30, 2013 EXRA
STATEMENT OF USE PROCESSING COMPLETE
Oct 29, 2013 SUPC
SOU EXTENSION 2 GRANTED
Oct 29, 2013 EX2G
RESPONSE TO ITU OFFICE ACTION ENTERED
Oct 22, 2013 IROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 22, 2013 TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 22, 2013 TROA
ITU OFFICE ACTION ISSUED FOR STATEMENT OF USE
Oct 16, 2013 INCS
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 11, 2013 AITU
SOU EXTENSION 2 FILED
Sep 11, 2013 EXT2
SOU TEAS EXTENSION RECEIVED
Sep 11, 2013 EEXT
USE AMENDMENT FILED
Aug 21, 2013 IUAF
TEAS STATEMENT OF USE RECEIVED
Aug 21, 2013 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 9, 2013 EXRA
SOU EXTENSION 1 GRANTED
Mar 7, 2013 EX1G
SOU EXTENSION 1 FILED
Mar 7, 2013 EXT1
SOU TEAS EXTENSION RECEIVED
Mar 7, 2013 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 11, 2012 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 17, 2012 NPUB
PUBLISHED FOR OPPOSITION
Jul 17, 2012 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 27, 2012 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jun 13, 2012 PREV
ASSIGNED TO LIE
Jun 12, 2012 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
May 22, 2012 CNSA
EXAMINER'S AMENDMENT ENTERED
May 22, 2012 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 22, 2012 GNEN
EXAMINERS AMENDMENT E-MAILED
May 22, 2012 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 22, 2012 CNEA
ASSIGNED TO EXAMINER
May 14, 2012 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 28, 2012 NWOS
NEW APPLICATION ENTERED
Mar 24, 2012 NWAP

Related Trademarks

More from this Owner

KIMBRIX THERAPEUTICS

KIMBRIX THERAPEUTICS

KIMBRIX THERAPEUTICS

KIMBRIX THERAPEUTICS

ZANOVERSE

ZANOVERSE

ZANOVERSE

ZANOVERSE

ZANPHOS

ZANPHOS

ZANPHOS

ZANPHOS